Genmab — Maj 2020
-
Sanofi har offentliggjort deres priser. Pr. behandling ligger de lidt under Darzalex, men fra år skal Sarclisa patienter behandles hyppigere end Darzalex, og derved bliver Sarclisa over tid dyrere, medmindre patienten får behandlingen kortere end 1 år
-
fra år 2 skal...
-
God morgen.
-
AlphaValue raises price target to 1700 from 1686, keeps reduce rating
-
11:37 ja, de ændrede fra akkumuler til reducer for et par uger siden. Jeg mener jeg postede det her i chatten.
-
den 24.4 kl. 14:51
-
Det vil da være dumt hvis man havde fukgt dette råd..;.)
-
fukgt
-
fulgt
-
Stoxx: Europæisk health care viser igen svaghed, er toppen nået?
https://www.proinvestor.com/investornyt/660462/stoxx-europaeisk-health-care-viser-igen-svaghed-er-toppen-naet -
handler 1888 nu
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind